<SEC-DOCUMENT>0001279569-16-004147.txt : 20160810
<SEC-HEADER>0001279569-16-004147.hdr.sgml : 20160810
<ACCEPTANCE-DATETIME>20160810082652
ACCESSION NUMBER:		0001279569-16-004147
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160810
FILED AS OF DATE:		20160810
DATE AS OF CHANGE:		20160810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31062
		FILM NUMBER:		161820043

	BUSINESS ADDRESS:	
		STREET 1:		1167 KENSINGTON CRES NW SUITE 210
		STREET 2:		CALGARY ALBERTA CANADA T2N 1X7
		CITY:			ALBERTA CANADA
		STATE:			A0
		ZIP:			00000
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		210 - 1167 KENSINGTON CRES NW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2N 1X7
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>oncolyticsform6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 14pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt/normal Times New Roman,serif; margin: 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 18pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Form 6-K</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 12pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Pursuant to Rule&nbsp;13a-16 or 15d-16</B></P>

<P STYLE="font: 12pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">For the month of      August 2016</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">Commission File Number 000-31062</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 24pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Oncolytics Biotech Inc.</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 70%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 24pt/normal Times New Roman,serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><I>(Translation of registrant&rsquo;s name into
English)</I></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Suite&nbsp;210, 1167 Kensington Crescent NW</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Calgary, Alberta, Canada T2N 1X7</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 70%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B><I>(Address
of principal executive offices)</I></B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">Indicate by check mark whether the registrant files or will file
annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 60%; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="width: 49%; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Form&nbsp;20-F&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&thorn;</FONT></FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Form&nbsp;40-F&nbsp;&nbsp;&nbsp;&#9744;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">Indicate by check mark if the registrant is submitting the Form&nbsp;6-K
in paper as permitted by Regulation&nbsp;S-T Rule&nbsp;101(b)(1):&nbsp;&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Note: </B>Regulation&nbsp;S-T Rule&nbsp;101(b)(1) only permits
the submission in paper of a Form&nbsp;6-K if submitted solely to provide an attached annual report to security holders.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">Indicate by check mark if the registrant is submitting the Form&nbsp;6-K
in paper as permitted by Regulation&nbsp;S-T Rule&nbsp;101(b)(7):&nbsp;&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Note: </B>Regulation&nbsp;S-T Rule&nbsp;101(b)(7) only permits
the submission in paper of a Form&nbsp;6-K if submitted to furnish a report or other document that the registrant foreign private
issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally
organized (the registrant&rsquo;s &ldquo;home country&rdquo;), or under the rules of the home country exchange on which the registrant&rsquo;s
securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed
to the registrant&rsquo;s security holders, and, if discussing a material event, has already been the subject of a Form&nbsp;6-K
submission or other Commission filing on EDGAR.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule&nbsp;12g3-2(b) under
the Securities Exchange Act of 1934.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 60%; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="width: 49%; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Yes&nbsp;&nbsp;&nbsp;&#9744;</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"></TD>
    <TD STYLE="vertical-align: top; text-align: center; line-height: 115%; font-family: Wingdings"><FONT STYLE="font: 10pt Times New Roman,serif">No
<FONT STYLE="font-family: Wingdings">&thorn;</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">If &ldquo;Yes&rdquo; is marked, indicate below the file number assigned
to the registrant in connection with Rule&nbsp;12g3-2(b):&nbsp;&nbsp;&nbsp;82&nbsp;-&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%; border-bottom: Black 1pt solid"><P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>EXHIBIT</B></FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NUMBER</B></FONT></P></TD>
    <TD STYLE="width: 2%; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; line-height: 115%; font-family: Calibri,sans-serif; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>DESCRIPTION</B></FONT></TD></TR>
<TR>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: center; line-height: 115%; font-family: Calibri,sans-serif; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">News
Release Dated August 10, 2016 - Oncolytics Biotech&reg; Inc. Reports Additional Data from Randomized Phase II Study of REOLYSIN&reg; in Non-Small
Cell Lung Cancer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 11pt">
<TR>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Oncolytics Biotech Inc.</B></P>
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">(Registrant)</P></TD></TR>
<TR>
    <TD STYLE="width: 50%; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="width: 5%; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="width: 45%; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">&nbsp;Date:&nbsp;&nbsp;
         August 10, 2016</FONT></TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">By:</FONT></TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman,serif">/s/&nbsp;&nbsp;Kirk Look</FONT></TD></TR>
<TR>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Kirk Look</FONT></TD></TR>
<TR>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Chief Financial Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED AUGUST 10, 2016
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><B>Oncolytics Biotech&reg; Inc. Reports Additional Data from Randomized
Phase II Study of REOLYSIN&reg; in Non-Small Cell Lung Cancer</B></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0; text-align: center"><B>--Study Demonstrates Statistically
Significant Improvement in Progression Free Survival in Female Patients with Adenocarcinoma--</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0">CALGARY, Aug. 10, 2016 /CNW/ -&nbsp;Oncolytics Biotech Inc.
(<B>&quot;Oncolytics&quot; </B>or the <B>&quot;Company&quot;</B>) (TSX:ONC) (OTCQX:ONCYF) (FRA:ONY) today announced additional
data from IND 211, a randomized, Phase II clinical study of REOLYSIN<SUP>&reg;</SUP> in patients with non-small cell lung cancer
(<B>&quot;NSCLC&quot;</B>). The study enrolled patients with both non-squamous (adenocarcinoma) and squamous cell histology. Those
with adenocarcinoma (n=75) were treated with REOLYSIN<SUP>&reg;</SUP> in combination with pemetrexed in the test arm versus pemetrexed
alone in the control arm. Those with squamous cell histology (n=76) were treated with REOLYSIN<SUP>&reg;</SUP> in combination with
docetaxel in the test arm versus docetaxel alone in the control arm. The study's primary objective was progression free survival
(<B>&quot;PFS&quot;</B>). Its secondary objectives included overall survival (<B>&quot;OS&quot;</B>), safety, and measurement of
biomarkers that may be predictive of response.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0"><B>Results in Patients with Adenocarcinoma by Patient Gender</B><BR>
An analysis was performed of survival outcomes for patients with adenocarcinoma by gender. The PFS was statistically significantly
better for female patients in the test arm (n=20) than for those in the control arm (n=16); median PFS was 5.39 months compared
with 3.02 months, respectively (p=0.0201) (Figure A). The evolving OS showed a strong trend towards survival benefit for female
patients in the test arm (n=20, six of whom remained alive at the time of the analysis) over those in the control arm (n=16, three
of whom remained alive at the time of the analysis); median OS was 10.68 months compared with 7.59 months, respectively (p=0.145)
(Figure B). By contrast, no PFS or OS benefit was noted for the male patients with adenocarcinoma.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 9.75pt 0"><IMG SRC="image_001.jpg" ALT="Photo_Asset_1" STYLE="height: 290px; width: 400px"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 9.75pt 0"><IMG SRC="image_002.jpg" ALT="Photo_Asset_2" STYLE="height: 329px; width: 400px"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0">&quot;We are excited to see a statistically significant improvement
in progression free survival for female patients with adenocarcinoma of the lung,&quot; said Dr. Brad Thompson, President and CEO
of Oncolytics. &quot;There is a significant unmet need for new therapies for non-small cell lung cancer patients.&quot;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0"><B>Results in Patients with Adenocarcinoma by Patient Genetic
Status</B><BR>
All patients were tested for biomarkers including those that are associated with the replication of the reovirus (namely, EGFR,
Hras, Kras, Nras, Braf and/or p53 mutations) (the &quot;<B>target biomarkers</B>&quot;). Patients treated with REOLYSIN<SUP>&reg;</SUP>
with one or more target biomarkers had a greater PFS (p=0.039) and OS (p=0.031) than patients treated with REOLYSIN<SUP>&reg; </SUP>without
any of these biomarkers. The presence of these biomarkers may account, at least in part, for the difference between the survival
outcomes for male and female patients; target biomarkers were present in a higher proportion of the female patients in the study
than the male patients (66.7% versus 43.6%). As a result, pre-screening for target biomarkers in patients with adenocarcinoma of
the lung is warranted.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0"><B>Results in Patients with Squamous Cell Histology</B><BR>
The overall OS for patients with squamous cell histology continues to evolve. Target biomarkers were present in a smaller proportion
of the overall patients with squamous cell histology (34.2% versus 54.7% of those with adenocarcinoma); therefore a larger patient
population would be required to make statistical conclusions about the role of biomarkers in predicting response.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0"><B>Next Steps</B><BR>
Based on the findings today announced from IND 211, the Company intends to include preselection of patients using genetic screening
in future study protocols.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0"><B>About IND 211</B><BR>
IND 211 is an open-label, randomized, non-blinded two sided (adenocarcinoma and squamous cell carcinoma) Phase II study of intravenously
administered REOLYSIN<SUP>&reg; </SUP>in patients with advanced or metastatic non-small cell lung cancer. Patients with squamous
cell histology were treated with either REOLYSIN<SUP>&reg;</SUP>&nbsp;given in combination with docetaxel (test arm) or docetaxel
alone (control arm). Patients with adenocarcinoma were treated with either REOLYSIN<SUP>&reg;</SUP> given in combination with pemetrexed
(test arm) versus pemetrexed alone (control arm). After a patient safety run-in, a total of approximately 150 response-evaluable
patients were enrolled. Preliminary data from this study were reported in May 2016. The study was sponsored by the Canadian Cancer
Trials Group (&quot;<B>CCTG</B>&quot;) at Queen's University in Kingston, Ontario, formerly known as the National Cancer Institute
of Canada (&quot;<B>NCIC</B>&quot;) Clinical Trials Group.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0"><B>About Non-Small Cell Lung Cancer</B><BR>
The American Cancer Society (&quot;<B>ACS</B>&quot;) estimates that approximately 224,390 Americans will be diagnosed with lung
cancer in 2016 and that 158,080 of them will die from the disease. Approximately 80% to 85% of lung cancer cases are non-small
cell lung cancer. The ACS identifies multiple subtypes of non-small cell lung cancer based on the types of cells where they originate
&ndash; adenocarcinoma accounts for about 40% of lung cancers and occurs more frequently in women than men; squamous cell carcinoma
accounts for 25% to 30% of lung cancers; and large cell carcinoma accounts for 10% to 15% of lung cancers.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0"><B>About Oncolytics Biotech Inc.</B><BR>
Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics.&nbsp;
Oncolytics' clinical program includes a variety of later-stage, randomized human trials in various indications using REOLYSIN<SUP>&reg;</SUP>,
its proprietary formulation of the human reovirus. For further information about Oncolytics, please visit: www.oncolyticsbiotech.com.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0"><I>This press release contains forward-looking statements,
within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the
Company's expectations related to the randomized Phase II study in patients with non-small cell lung cancer, future trials in this
indication, and the Company's belief as to the potential of REOLYSIN<SUP>&reg;</SUP>&nbsp;as a cancer therapeutic, involve known
and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking
statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and
development projects, the efficacy of REOLYSIN<SUP>&reg;</SUP>&nbsp;as a cancer treatment, the tolerability of REOLYSIN<SUP>&reg;</SUP>&nbsp;outside
a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize
REOLYSIN<SUP>&reg;</SUP>, uncertainties related to the research, development and manufacturing of pharmaceuticals, changes in technology,
general changes to the economic environment and uncertainties related to the regulatory process. Investors should consult the Company's
quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties
relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements.
The Company does not undertake to update these forward-looking statements, except as required by applicable laws.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0">SOURCE Oncolytics Biotech Inc.</P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0">Image with caption: &quot;Figure A - Progression Free Survival
in Female Patients with Adenocarcinoma NSCLC (CNW Group/Oncolytics Biotech Inc.)&quot;. Image available at: http://photos.newswire.ca/images/download/20160810_C8986_PHOTO_EN_750540.jpg</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0">Image with caption: &quot;Figure B - Overall Survival in Female
Patients with Adenocarcinoma NSCLC (CNW Group/Oncolytics Biotech Inc.)&quot;. Image available at: http://photos.newswire.ca/images/download/20160810_C8986_PHOTO_EN_750542.jpg</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0">$CIK: 0001129928</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information:</B> NATIONAL Equicom, Nick Hurst, 320
Front Street W, Suite 1600, Toronto, Ontario, M5V 3B6, Tel: 416.586.1942, nhurst@national.ca; NATIONAL Equicom, Michael Moore,
San Diego, CA, Tel: 858.886.7813, mmoore@national.ca; Dian Griesel, Inc., Susan Forman, 335 West 38th Street, 3rd Floor, New York,
NY, 10018, Tel: 212.825.3210, sforman@dgicomm.com</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0">CO: Oncolytics Biotech Inc.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 9.75pt 0">CNW 06:30e 10-AUG-16</P>



<P STYLE="margin: 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" $B 9 # 1$  A$! Q$!_\0
M'0 !  $% 0$!              8! @,%!P@$"?_$ %D0  $"!0,!!0,%"P@&
M!P8'  $" P $!081!Q(A,0@3(D%1%&%Q%2,R0H$6,U)6D9*5EK'4\!<D0U-B
MD]+3"51CH<'Q&"4T5W*"T1DF-3=ULS8Y1$9WHN'_Q  : 0$  P$! 0
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MF#\H2TR2V%S!)3DL$E0&3]9/$!]Z==='%3-0ETZF6PIVEO)8G$BIMDM+4O8
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MHH'IS 6*[0>CJ;#J]Z*OJGB@T2J*I4W/[7.[5-A*5EIKPY>.U0([L*!&<=#
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MEL;P/_%U@,T @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
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M@<C, @$ @$ @$!:\L-ME:L8'J0/VP%T @$ @$ @$!:ZL-HW*QC(') ZG$!=
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MQYP&*<4^)<E26T_1R0YCSYY(QT@,H+_&4-^6?&?M\OA  7^,H;\L^,_;Y?"
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M#HVE]/OV5E)N:O\ N"E5"=G'$J:DZ13U2\I3T@8*$*6I3CI)Y*UD>Y*1 2F
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M:JR-4JU-G:13GIV4F*947I1Q#J$'&5-*25)Y^BK(/'' BDM(=2=2+ZDZC<%
MLVS:A7I*WW:E3I,3?M3SZIB6:2M"WIYY92Z'7%+0&^%C"/$=WA#<:<7W=-S:
MRT65:K].FK?F+6FIJ<831'I)XSC,\)=8+;JRXRI"O"IM><%*QR2" U6IFN=:
MMRX+@:I$I3ZO(R%/JRY12I)^72B;D&VU+94^I9#V5*6A7=H2$$?260H ,E>U
M,U-D;^^Y9MNT^]9K%.HC\PJ5F2DOS<FN8+R4]Z/ V48V$Y<!^DWCD.F:+71,
MWKI50;IG)5J5F:I(H>?9:45(0YR%;2>=N0<9YQB E$!&[^_^)VU_];1_]A^
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M2XD@'!(R/(P'CN=D6ZQ<U.F9:AZ%V?2:[,UR6IC58L1AWV-ZG3(93+3#Y=0
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MYJ*;]-NY,3$Q/*)CECOGJZ;&8OD @$ @$!BGCB64=V.G.[;YCS@,L @$ @$
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M+Y6K6F=GOS5P5)"BM+D_/!##+160-Z@RS,**L9/A41XH#T) (! (! (! (!
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! 42 !@ #X0
M%8! (! ("@ !) &3U@*P" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
M 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
M 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
0 0" 0" 0" 0" 0" 0'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" %) 9 # 1$  A$! Q$!_\0
M'0 !  (# 0$! 0            ,& 04'! @""?_$ &(0  $"!0($!  &#0@%
M!@D- 0$" P $!081!Q(3(3%!"!0B414C,F%QD0D6%S-"4E:!EJ'1U/$D-%>5
ML<'2\$-$56*4)393=++3&#4X1G)S=9/$)B='2&1E=X*%HJ.SP^'_Q  : 0$
M P$! 0               P0% @$&_\0 .Q$!  $# 04$!P8%!0$!      $"
M Q$$$B$Q05$%$V&1%!4B,D)3<5*!H;'1\",T8I+!5'*"LN&B,__:  P# 0 "
M$0,1 #\ ^_H! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M (! (! (! (! (! (! (! (! (! (! (! (! (! (! <P\0>OFGFC%0I$E>\
MW4&7ZXEU4DB4D%S!7PR@*SMZ?+3 5YGQ1615=(Z_?MHT.Z+B8MV9EY>9D):E
M+;FG%/* 26T+QN !R3V @.Q6S4Q6+;I]7$L]*"?E&ID,3"=KC6] 5L6.RAG!
M'N(#W9'O 8R,9R,0&<CW$ ) ZD0" Y/KEXB=-])KUD[4NR8JPJD_(B>89D:6
M[-;FMZTY] //+:N7S0&]T&UAT_UBH$U5K"K?P@W(/!F=9<86R]++() 6VL @
M$ X/,'!P>1@+W (#P7/6J3;MOSE<KM0EZ?3:>RI^:FIAP(;9;2,E2B>@@.*6
M=XP]#;CNV3H4O7ZA)BIOEBG5"HTMZ6DIQS.-J'EC Y\LJ"1V@.]9&<9@&1G&
M8 "#T(@,9'N(!D9QD0',-6-9Y*Q]<K"TV?H4Q./WTX^VS.(F$H1*</;DJ202
MK.[L1 -)=9I*^=<+]TW8H4Q)OV(ZPV]..3"5HF^)NP4I !3C;W)@+)K-J39N
ME5DNW7?-9;IE-;<2TE90I:WG%9*6VT)!4M1P3@#H"3@ F K&@'B!T_U@K$_2
MK455VIVGRR)IYBI4QR6)94K:E:2<@@GYX#J61C.1B SD>X@ (/0P%&\0FI+>
ME>GRKI<MFMW$E,VU+^2HS =F/7GU;?Q1CG](@+I(OB9DVG]BD<5M*]BAA2<@
M'!^?G 2Y'OT@,9'8@P',/#;K-):NS%WM2="F*7]J5>=H[A>F$N>84C/Q@P!M
M!QT.?I@-GJKJ:W9-^V;;"[6KM65=\\J43.4^7"V*=A3:=\PK\%/QF<^R5>T!
M?,CW$!F Y%KMXDM,=(KVE;4O&<JC=3G)%,\TU)TQR8!:*UH!RCOEM7* MFA^
MIMKZKV8NZ+2<G5T]N;<E%&<DURZ^(@))]*^>,+'. N(((SF QD>X@,Y&<9@,
M9&<9$!S#5;6:2LC76P]-'Z%,3;]]+?0S.HF$H1*<+&=R2"59SV(@.GA0P"2!
MF S (! (! (! (#XS^R.U*M4?Q6:#5.W: JOU65GIQR3I:9E,N9QP.2V&^(K
M*49]SR$!8O$9JYK-)^"^]+QJUE3>F-PTN<DFJ<6ZJS/+=:6^RE;@4E.$_*4G
M!'SP&KUBU#U-NS4S1C1>T+UF;9F+NMMFM5ZN2[*%S*TAA2RE&1@9X+A.,9*D
M]@00\%F7YK%0M=]9["NJ_GZRFR=/'YNE32)9MG>Z&FW&II2 " ]M6 K\$J!.
M.<!J;XUCU-DOL5]LZE2MX3S=USE2#4Q50$<5Q'FYA&#Z=OR4)'3M ;W5^Z]:
MKD\:4II'8FHB[<D*S9+$Y,S3DJE_R)]2G'VD<B75;$H'J& LGD0" T>L6MDZ
M_P"(>M:97!KO/Z<T2QZ3+2R:C(TTNS-<J2FD%;KA"%E+:23E'+/TG(#N'V/C
M5.X-6?#XW6;K?;FJS2JD_2YN=;9X0G>&$*0]LP "I#B<X &03@9Q <B\5U9N
MR@?9+]/ZG9-H"ZZTU9CX8I)J+<EQP3.!9XRP4IVI)5SZXQ ;;[&JJ5F]3]7Z
MU<"#1[]JE<2[7;8$MPFZ4@+>+>Q>2'=Q6K*ACH/Q@2'<=:=<+(TMK<G2KH36
MS,3TN9AKX/HTQ.)V!13S4VD@'(Z& TVGGB7TUO2\Z?:]%3<OGZDX6V/-6[-,
M-9"2KU.+0$I&$GJ8#FOV8&HSLKX5Y*0EGG&96KW-)RL\I)P"T$.N 'YM[:#_
M /E$!M_LB=GVQ+> .MTV7D99J4MJ5D5T@(2 )92'FFD[/;*%J3RZA1@*99.I
MNH=O:M>'N;KEP3R[4U'L^7D9V2=VEL5,2XVNY(W!2U+8/7GE4!KWO$)?M*T]
MUTUF;JS\]1J;<"+>LF0?;295EQ*PVI_  *AA:%\R<G([P&CTFUZJU"UNTUD*
M=KO.ZFRUXS"*?=5-G*6644R9=V!#LNKA(VH"UD8!(P@Y',;0N&A=:UOU.\46
MHE";U,=I=IV#? ==ES*)=>G60^X$2*5#;L9*&E[CS.2GD>P5;Q0:HU>C3MYW
M#9/B9N*HUV@3RWI>A4BVB_1Y%H.@"5?F$-*:*DIR"M:L$C!'. V^K%R3%X^)
MKPHW9.-(:F:Y3ES[[;?R4K=996H#YLJ.("S>#O\ \O7Q#?\ 7)'_ /T@+A]D
M)T9NG5W32CKLE^4-?M:K)JDG)SJ@&9W"2"V2KTA7R2-WI/,$C.0&DT*\2M1O
MC[:["O>T)JRM3+:HDQ-/RJTY:>2AO/$9*O4G!4A6TE0((*5*&<!S)K674\_8
MI'=3#>,]]MB:KP15MJ.+L\^&]OR=OR#CI ;O5>]M::WXG-.],[&O]5#1>&GS
M,U.S3\LAY$LZ4O+=FD(P-SNQK">8&2#RZP%JMF\;[TV\<4AIS?%[3E:MJX+)
M1,R#TVE"4IG99H>8<&!D%7EWUE)4<<0?- <CN?6/6)7@7NK6EJ]:G)S->O<(
MMX)0V/(TY+JD!M *>A5N2<Y/H'SP'9I^_P"]K2\>MHVY6[CF7[-U M8F2DW0
MD-2T^TWN64G;G)X8/7&7OH@*SI%J==EV:$:I:I7)J[]IE#JES+D[6JDU+-OM
MTJ2:>&2RT1\8MQ*BV!S.4Y'2 T_AXU:N61\8-L6+3]4KGOVT;OI4P\7+EH3D
MB]+OM-N.!;*G&T%:#PQS3Z<+((R 8"S_ &,#_P 8ZS?_ (A3?]JH"S^,:^[N
MM3Q :&4.WJ[,T^GW+<SDK5Y=H)VSC0<E@$+R"<86OICK <V75]<-2O$_K+I]
M;>KDY:]'M<-34HIN2;>=;5P\H8;5R+;:E%16K)5Z4@=3 =<^QT:DW/JCX8J9
M<%X30G*O+3DQ(OSFP)5,AM0VK4$@#=M4 2!SVYZF XWXK:[==M_9.['J]EV<
MN[JRS9;@8I"9Y$H7PHSJ5'BK!2-J25?/C$!O_%!XA-2K:TGM"3KU%3I17[SN
M!R0FIQZ814S2*>T6^),HV)(4LAU.!@D *QS(("KZ0:\5EF_[_L&A:K5#4&@)
ML>=K-!N&<DN#.2$XRR2II2BVG>!\KF"!A..X(46J:E^(VD>$*S?$&O5]Y\FL
M>0%#73V^%-M<9Y)<F%]7%*4V4XP $;<$*!)#L%CW)K)I[XYK/L*]=2W+NIE_
M4%^?FI9<BB79I[Z4/+VL)&2E*5-8',92HY&0# 4WQ/:I5>C3=Y7'9'B:N*I5
MV@SZWI>A4FVB_1Y%H/ "5?F$-*:*DI)!6M6"1@C)@-WJO<<Q=_BC\*EUS;2&
M9BN4M<^\VW\E"W6&EJ ^;*CB K6J?B$G[GU6U(EGM=IS3=BS9AVG6K29&F%[
MX4F6=X6[,KX:LI4X@)"20 %#ER.X/JCP9ZC5/5;PWVU>M;90U59QEQF?"&]B
M5/,NK:4L)[!6S=@<ANP.D!U" 0" 0" 0" XCXA]&;AO_ ,0^E5_TNI4R7D+$
MGGIBH,3*W \^E:FE -!*2DGXL_*(ZB WGC(TSK&KGAVKE@4"=D)*H5-4L6GY
MY2TLIX;[;AW%"5*YA! P#S@.3Z_:23K%X:57-:>I%IVWJ/9%%1)LR]<?*96J
M2S;8;<P.2RD*6X#@<P[U20# 4+PH46<OOQC:VMU>ZY:YDU.U$TFKUREM!,IY
MA]+2%-RXR?0V$.(3DDGA9/6 Q4/"/X@JGX=/N+SVH=FBW*+4/-T5+;#X=FB7
M5*(F'-A*$I#CBDI2%$J5@JPD0'=9#16Y&?&C(:Q.5*E&CRMH)HCDH%N>9+PS
MZ@-FW9SZ[L_- :G4C1G5*W?$'6-7-#J[:[4W=,FU+U^BW,R\95];0 0\VMGU
M!6$CERY[CD[L .P:/2E]R=DLMZCS]$G+@6\XN8716%M2B$E64(0%^H[4X&5<
MS <<\1NC&K-P>*&W-8-,*[:4C,T&@KI@:KR7UA2EJ?W*VMH.1L>Y>H<QT@-M
MX2="[CT[O.[]1-0KJE;AO*]'D*GG9%@M2LNV@DA#8(!.>7/ P$I '4D.ZD9]
M_K@  ^?ZX"B>)/2RB:RZ052PZXZY+-SR4N2TVTG<N4?0=S;H!QG!Y$9&4E0R
M,Y@. UWP^^(O4.T:1I?JEJ5:R[#ICK'FIFCRKPJE6:9QPT.E:0@'D/4#U 4=
MY$!TOQ>Z&3FI>D%OV[8<](T"LVC4Y2=H,T^I:6Y0,IV; 4I4H )VD<CS0F U
MMN>&6GGP/C0>OU)H3<RPI^;JDHDK GU/%\/)"MI4D+VIP=I*1CEF ]&B]M^*
M"C5JA4:];CTZF[8HP2U,3LC*S)J=0:0V4H"MX#:%?))(]OK#8^&C1ZX-.M5=
M6+GK-2ITS*W]7A49!$FMPN,-[GU%+NY( 5\</DDCD><!QNG>%_7*D:+7?HG1
M;SLI%F5J:?G)2H/2TQ\)O*6I"DLNX'#0DEM.Y8WJ R$]>07E[P\7>[>N@M:5
M5Z(&M*J6).KH#CNZ:4&FT98]&",H/RMO6 M.A&CEPV1XE=4=1:E4:8_3KY?E
MG)!B76X7V WNSQ0I(2,[N6TF M7B"I^KL]0*>YH]7+?IM5EISB3;==86Y+S;
M&Q0X>4)*DG<4JR,=.ON'+-#/#W? UEN75O6FZ*35+DKU'51V9.@LK;E9*74E
M*%$*6 2K:D #'+*B2HGD'+/_  1=>_N 5;1,:AV@+1:GS/4G,N^)B:7Q0L(?
M7L/";'->$A9WX&=L!VF4T,N=OQ5:>ZGKJE)^#+2LX4.=E@MSCNOAIY&]L;-I
M1ET<R0>1Y0'X\=F@US:R2%M5*Q:[3J)<EO/S*$3DZIQ"52TPR4.HW(0HY)">
MV,%4!XM<?#?5;D\$U#T/M*I4N4G*0B1"IJ=4XEAU362ZOT(4K*UJ4H<N_: V
M/C+T*N;5:P[319E=D*-=5ISJ7I.?FUN);2VIGANI!0E2@24MD<OP8#1:C>%Z
MI5/P:6=I-;E=I\E7+.F9:I,S#[2E2<Y.(XA=#@P5;%+>60=I/(9',P'[H.C&
MM5;\4MCZS:BW%9JUV[)34G-4JBMS*&F4+;=2DLJ<!+BE*=*E%12!@  XR0MG
M@]T<N'26:OYVO5&F3@NNZ'ZO*>16XKA-+SA+F]*<*Y]LCYX#]^);1^X-1M8=
M*+MI%1ILM*6%75U&H-3:W X^V5L*VM;4D%7Q1^44CF.<!YM)-%[CM7Q(ZK:B
M3U2I;U.OMMA-/886X7F"A)!XH* D=?P2J ]G@8TCK^BFAB+*N.H4Z>G4U.8F
MN-3U+4UL<*<#*TI.?3SY0'GN[1NX:MXY+6UJ8J-,11:%;SM,F)1:G/-..*$R
M I("=FWX]/50/(\H#V^+G1N?U5HMO5*V*\U0KMLVJHJM!GWV>(R'1C<VZD<]
MBMJ#D X*1R()$!K[6MCQ#7#;ET4G5"IZ>M2U4MV;IM/8MYB9!\RZC8EYYQT9
M"0"H;4^_S0'/;E\+5[U'P$6YH8S7: FN4>J^<?G%N/>46CCON820WOSAY(YI
M',& Z'?VC%Q5WQ?Z?ZL2U3IC=(M.BS$A.2RUN"9=6XV^D*; 3MQ\:.94#R,!
MR"G>%[7.D:(W;HC1KSLINS:Q-/S<I4'I:8^$WU*4A267<#AH02VG<L;U8R!R
M/(+V]X>;O=OO0:N*J]$#.E=)$E5T!QW=-+#*&\L>C!&4$^HIZP$<_HQK-IWK
M#=EV:%UVS'*3?$VF?JE&NIA_;*S?JW.LK9&2"5J.#CKC!P# =YTUE;HD[&IT
MM>D_3YZO(9_Y0F*<P6I=;A43\6D\PD @<^9QF WL @$ @$ @$!%,3##! >>;
M;*NF]8&?K@/VTM#B MM04D\P0<@P%)U?T>TTU2,H;^M"0K:Y%*DRSC^]#C25
M$$A*T*2H D XSB V.E>GED:;4!5$L:VI"AR3CG%=;E&\%U>,;EK)*EG&!E1/
M+E ;&UKIMJY3."W;@I=6-.F#+3GD9Q#_ )9T=6W-A.U0]CS@-M (! (! (!
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M-RIEDS F&BTOY+G$&U7T'H8": \\W/R4JZAJ9FV&5N_(2XZE)5] )YP'H@$
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MIY>]PH;0$)*E=U82,GN8#80" 0" 0" ^3_'58\U>?BNT+:F+3F:[0&JA-(K
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M_!5ZB,=1@D.3?9,[9O:EZB6_J'I];53K,[5K<JEJ5)-.DW'EM-OM*#2U;$G
M!><()[I'. HWB?T>O:W[[M_3:S;=J4Y0K]M.@6[69Z3E'%M2;DE--!3KJT@I
M2-B$DE1'(J@.PZS6I5F_LAVBD[2+?J"Z%1:+-RSLVQ*+5+2@#4PE"5N ;4<M
MH )'40&GT\F*UIU]DDU!77+,N5^GZ@^0:H]4D::IZ4&$MA2W7!@(2DA04>93
MMYCF("IZ%VA=<IX*/$+2INUZRQ/U2LU1<A*.T]U#TVE3* DM(*=RP2#@I!S
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M$!G'/, Q 8 _SF S ,<L0&,<L<_K@,B $0" =X!CGF 8@$ $ Q 8P/\ )@!
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M$ @$ @(IS[R/_33^ 5?A#L/[>W6 E@$ @$ @(IC[XS_ZS\0G\$_5]/YN\!+
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M<=FSE1G&YY;90A^6GVI=M;24I3LRVX0K')1 4>>20^BX! 57_P"FC_\ 0/\
MXF M4!%,@%QCD#ASNC=CTJ[]OI_-W@)8! (! ( >D!\T:VZFUO3O46H(HNOE
MI5*9F9H\&R*M0G)Z:E20#PFU4\F83\W$;5C/M ;FP/$3<GD:7,ZI:,759<G5
M)YF09JY2'Y)+KK@;;+J5;'V$K6I(!6WU4,X@._" 0'QYXHYNE6YXD;TJ53T\
M3JHJIV&V&Z>S)^;<M@-%P$O)*2&F'RO?N02Y\6HA!'. QX1;&MN^KMN"W[V>
MI5\2=J6%;U$IDXZ@3+!:FI9Y]]Q@K&1E12@+P%8:2#C& '5?!5>DM_X'ECU:
M\+@E)98EW:<F;J$VAKC>7F'6$>I9&Y10R#[\C 6SP]SLF_HE)/LS<NXTXJ=6
MAQ+XV*29M_U!0[?.("_!]@)YO-C&<^L<L=?J@,\=G=CC-YSC&X=<9Q]7. K&
MJ:\T21GY>1%3^#:G+3BY=E;I>4@+QN:2TH;U\\A*O0<'.<1#>B=F)B,XF&GV
M553WM=NJO9VZ:J<SC&9CG,\(\8W]$LS>DNPMY/P#7G RJ;3N;D<I6&$A6Y)W
M<PX3M;/X2@1RCV;N/AGGRZ?KR<T]G[41/?41G9^+[4XW_P"WC5TA[[<N&2K*
M9HM,S<J9-_@.)G&"R2OAH<5MS\H)"P"1R"@H=HZHKBK.Y7U.EJT\T[543M1G
M=,3SF-_3AG''$Q/-RART;1M3Q1V^JV*'3*6JH6S6'9PRC8:XZN+*$*64\\^I
M1S\YC=G57K_9MSO:YG%5.,\MU3#[BW:UM&Q3C,5?X=KXK?9:?KC%RTSBM_CI
M]^L,C!?8!(+S8()!!4.H&3]0@ ?8) #S9)( ]0YYYCZX )B7(R'VR" <[QT)
MP/UP$,_,,>3=R^T,)43EW:!CKDCIB FX[(44EYO()!&X=0,D?5S@ ?8) #S9
MSC'J'//3ZX!YB7QGCMXQG.\=,XS]?* &88&<O-C&<^L<L=?J@''9SCC-YSC&
MX=<9_LYP$,],,&45\>USVXR[M',\N8]^WO 2^8E\9+[>,9SO'3./[>4!DS#
MSEYL8SGU#ECK]7> <=G=MXS><XQN'7&?[.<!K[I?85;%1VO-G,FX1A0[H5CZ
MX"/3S_F%1/\ V;+_ /\ 4F W$ @-==55H=$H;U5N.H2%/ITJ4K>FI]Y#3+7J
M&TJ4L@#GC'SXQ >*WW+.NJ2%S495%K#%094P*C*AI],PV"4J1Q!G<D$$%.<
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M<K*)9HXEY)8<E6@EK8PH=%(3T2>9YC$!ZC-T4J*C,R!)<#A/$1G>!@*^G'>
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MM 8$PV0#ASF ?O:NYP.W\( 9AL G#G($_>E=CCV@,E]L$C"^1(^]J[#/M_&
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M#JD*S@C'+/?M[=3B F#B\XX#G4#.4^V<]?S0& ZL@$R[@R!RRGED\^_;^&8
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MTGYH"TP" 0" PKI^> HN@&?N.2FW=GBSV-N,_P [?Z9Y?7 7I/R1]$!F 0"
M0$<YN\HYMW9V'&W&>G;/+ZX"2 0" 0" BG=WE7-N[.WEM(S^;/* TM4H-2=N
M7X7IMR3TD'&2T_** >87A"PA2$*Y-J"UA1*?E[$I/(1'515M;4587K6KM4V.
MYN6HJQ.8GA/&,Q,QQB8C$9X9F8WHY:C72AUE3MY+=2A<H7$_!K*>*&T$/#(Z
M<91"LCY&,)Y&/(HN?:Z<O/S=U:G1S$XT^/>^*K=F?9_MC=_5S1(H5W"52V;Y
M<+HET-EWX*8YN!_>IS'3U-?%;>@^4.<>;%S'O_A'7]PZG5Z':SZ-NS,XVJN&
MSB(^ZKVL\>7!I;UJ%V6[6I%:;B;=DWES+COF*0IUM*5S4LAED\$;P4(=<2%=
MSZE\DF([E5RBJ-^[?R\8QP7=%9T6JM5Q-K%4;,1BN(G=17-4^UNWS$3,<N%.
M^8="BT^?13N[RRMN[/+Y)&>OS\H#C]XW;;%H>+4SMTW!3:-+S%CMMLNS\REE
M+BQ/.':DJ(R<<\1M6=->O]F;-JF:IBOE&?AAF7+UNUKMJY5$1L<_K*S_ ';]
M'_Z3+5_K9K]L5?56N^35Y2L>GZ7YD>9]V_1_^DRU?ZV:_;#U5KODU>4GI^E^
M9'F?=NT@_I,M7^MFOVP]5:[Y-7E)Z?I?F1YGW;]'_P"DRU?ZV:_;#U5KODU>
M4GI^E^9'FCFM;M(BR0C4RV,Y'R*LSGJ/<P]5:[Y-7E)Z?I?F1YI/NWZ/_P!)
MEJ_ULU^V'JK7?)J\I/3]+\R/,^[?H_\ TF6K_6S7[8>JM=\FKRD]/TOS(\S[
MM^C_ /29:O\ 6S7[8>JM=\FKRD]/TOS(\S[M^C_])EJ_ULU^V'JK7?)J\I/3
M]+\R/-L[3U.T\N>LHI%NWK0JI/N(4M,M)S[;KBDI&5$)2<X B*]H-59HV[EN
M8CK,.[>JL7*MFBN)GZK/-9X0V[L[T_)QGY0]XJ+"2 0" 0" C?W<1K&['$YX
M(Z;3USV^B D@$ @$ @,*Z& ^0]:+(K4_5Z_?]]2U^3;%'U!0S-2U+J4ZRT+:
M+ 2A<JS+K3O"5N(<<4@%>4._00Z5X&&)-BU[N50$W$_:[URK<M^H7 J9\U.R
MYEV-QVS'K#:'>(A!PG(2"059)#N< @.7ZP:Y4+3FKS<M5K2O6?DJ9+HF:I5Z
M70E/R-.:5D[W72H9  *E! 44CF1 8U"UZLZV)R2E9.G7!=+TW1TUMQ%MT[SA
ME*<KY,T]ZD[6U<\ 94<'"3B Z#:U;I5RVS3[@H<ZW.TVJ2S<U)S+?R76E@*2
MH9Y\P1R/. J>@8SHU*C .79[D4;O];?[=_H@+VGY(^B S (! ("*>&9)T$ Y
M0>11OSR_%[_1 2P" 0" 0$,^ 9)P$ ^GH4;_ -7> F@$ @*WJL^B7L]3KDRB
M73YV43Q%U14@,F8; '&2">><;,>O.PX"HBO3BCRYXYM'LJB:]5B(SNJ^&*_A
MGX9_/X?>Y+&"(E9R*?P918(!Z<BC?W]N\!^9N0D9IP+F927>4!@*<:2H@>W,
M1U3753PES-,3QA#\#TC_ &9)?\.C]D==[7UEYW=/1D4>D@@BF28(.?YNC]D>
M=[7UD[NGHU=F6A3*%;4K2G)>4FU2P4.,J52"K*U*Z<_QL=8EO:FNY<FO.,^+
MBU8IHHBEM/@:D_[,DO\ AT?LB/O:^LN^[HZ(9VCTD2YQ2Y+JG_5$J_"';'\.
ML>=[7UD[NGHF^!Z3_LR3_P"'1^R/>]KZR=W1T/@:D_[,DO\ AT?LAWM?63NZ
M.A\#4G_9DE_PZ/V0[VOK)W='0^!J3_LR2_X='[(=[7UD[NCHYU?\G*2GB2TT
M\K*LL;Y2M;N&V$Y^)8ZX$:.GJJJT&HS/.C\Y4KU,1J[.(^U^4.FSH!8&0#ZT
M=4;OPAV_O[=>T9302P" 0" 0$4R,N,<@<.?B;L>E7?M]/YN\!+ (! (! 85C
M!ST@/E'5,T%6KU=3I$SK9]M_GU_"JK464T<S>!GS'PA_)/;Y _O@.U>&3[K_
M -S]W[LRZ2JM^<5Y7R&W>);:G;YCA_%\;=OSP_3C&(#HL @.,^,BYIQVS$:2
M6FE,U>&HS3M*DV<;A(R:T[9J>>'X+3;2E<^ZBD#/. T'AHH4A:WB;U5ME)49
M2BV[:TC3R_U\DU)/-_5N2K/SP'H\"CEQM>"NQ5423D)ITIF=J*A-N,)$MYN8
MX92I#:R3LV8& ,=X"\^'E4[]Q&15--2R'<SI<"'U;$J\V_D!6T'&.^ ?F@+^
M#,;>2&CUQZS^;M]?]\!D%_=S0WC/XYZ8^CW@, S.!EMKMG"S^?M]7]T S,[?
MO;6<'\,]<\NWM "9C)PAKJ<>L_F[?Y^> BGE/"3=*DM!.PY)=*>6WGS Y<X"
M4&9P,MM9P,^L^_/M[0 F9P<-M9P<>L]<\NWM "9C)PAO&3CUGICEV]X#(,QD
M90WC(SZSTQS[>\!@&9QS;:S@9]9ZYY]O: BGU/B3=*DL@;5<RZI(Z\LD#E\_
MM\\!,2_N.$-XR<>L],<NWO 8!F,C*&NV?6?S]OJ_N@&9G;][:SC\<]<_1[0'
M@N2GSM4IAE&9Q4BKC(<#S.U2B$.)7MPM!&%!)23C(!..>".:Z=J,9PGT]Z+-
MS;FF*MTQB<\XF,[IB=W&/QW-7,VY<+C#K:+TJ;1<:F6TN):ERILNN!:%@%K&
MYH MI!Y%)RK<KG'$VZL>]//I^]RW3K=/%43.GIG$T\ZM^(Q,<?BG?/CPQ&YB
MJ4.N*2\Z;MGFD+?==#8#(2A+C0;#8/#SM;4.(D]2HX42GE'LT59]Z?P_?BXI
MU=F*8B;%,[HC.:N4YF>/&J/9GECAB=[]R] N!MUI:[NJ#H;<EEJ0I# #@:04
MK2<-<@Z2%JQS!&$[1'D6ZOM3RZ?O>]JUEB8F(T],9BKG5NVIS$\?AC='6..9
M:ZOTBXZ5:4[-&^9P.25-)\S-(92C>TXIXNN;63C<GXM> <(&4C=SCBJBNFB9
MV^$>'UZ?<LZ?4Z:]JJ*/1HQ55PB:LXF(IQ&:N4^U&9][=,XW+/0)R8J%$DIX
M^47YJ7;=*V'%%M04@*R@E()&3RR <<S@\HFIG-,2S-1;[J]7;C.Z9C?QW3S\
M>KU@S/++;7X.<+/Y^WU?W1TA,S.W[VUG!_#/7/T>T!%/J>$NK*6<;AC<ZI/<
M8Y@?Y^> FS,;OD-XR/PSTQS[>\!@&9P,MM9P,^L^_/M[?Y$ )F<'#;6<''K/
M7/+M[0&29C)PAO&3CUGICEV]X#FFHY=_\)+3/>E _DE:Z*)_T#&>WO&GI?Y#
M4?6C\Y4+_P#-V?\ E^4.BS:G^ -Z&1ZF_P#2J SO'?'U>YY1F+Z4F9P<-M=#
MC*S[\NWM_DP&29C=R0WC)_#/3'+M[P& 9C(RAK'+.%G\_;ZO[H!F9Q][:S@?
MAGKGZ/: $S.#A#7X6/6?S=OK_O@(YA3O&9W):'QOIRZ03Z#VQS.>WMS[0$[1
M<(^,2D' ^2<_3V@/U (! (#17_;:[GI<K)MW#6Z(96?8G"]2)H,.O!I6[@K)
M2<M+Z*3W'+(@/F_5^:-+U4KCEWWIXA[-I2YQ:V*E24LS=##?+!;4S+NN,I_W
M7!RY\X#L_AD-N.V&_,VQJM5]19)^<4LU.J5%F;>EU;$@L9;;1LQ@*V*3N!4?
M<0'1H! <FOK0&W;DU2J&H+=WWQ0ZU4Y5F4F'*)7E2B>"V $M@!)(3D;B,X*B
M3U,!^[UT"M>Y33YA^Y+QD:E*4A-&G*I(5M34W5Y('/!G'-IXH)*CNP% J5@C
M,!T:V*+2[<MJ0H%$DFI*FTR6;E926:'I9:0 E*1]  @*IH#G[CDIMW9XL[C;
MC/\ .W^F>7UP%Z3\D?1 9@$ @$!'.9\H[MW9V'&TC/3MGE]<!) (! (! 13N
M?*N;=V=O+:0#^;/* E@$ @$ @(IW=Y96W=GE\DC/7Y^4!+ :V\5K:M&JN-N.
M-J1(O*2MN92PI)"%<PZOTMG_ 'E<AU/(1Q<]R5G1Q$ZFW$QGVHY3//I&^?I&
M^>#]VHM3EKTUQ:UN*5)M%2UOI>4HE YEQ/I6?]X<CU'6/:/=AYJHB-17$1C?
M/*8Y])WQ])WP]\=*Y 13F[@';NSE/R2,]1[P$L @$ @.9:V4Z[T:EV7=EK6L
MJX44-JHM3<LBH,RJD\=MI*"%.D \T*Z1J:&NQ.GNV;M>SM;.)Q,\,]%#547H
MO6[ENG:QGG$<<=6'KWU7*,'1*>3ZAS%SR'N.7,P]$T/^IC^VH](U7R?_ *A^
MOMXU7_H/G/TGD/VP]$T/^IC^VH](U7R?_J&MO#5C4"U;:G+@KVC,]*TVGM\6
M9>3<<DX6T9 )VI))Z]!$MGL[2WKD6[>HB:IX>S4XNZV_:HFNNSB(_JAUU!W)
M!QC(S&,TF8! 1OYXC.-V.)SP1^*>N>WT0$D @$ @$ /0P'RW.U6D7IJ]>M%U
M%\1%9M1FWZXJ6E;6DZQ)T,+E2VA3;AF$'C/H6%'/K2I)!! Y0':M +?TNMRT
M9F2TH72':6N=4[./4ZH^=+LR4IW*=>*UJ4X4[<E2LXQ 7J 0" 0&%=/SP%$T
M#&=&I4$ Y=GN11N_UM_MW^B O:?DCZ(#, @$ @(IX9DG00#E!Y%&[/+\7O\
M1 2P" 0" 0$,^ 9)P$ ^GH4;_P!7> F@$ @$ @(9\9E%@@'IR*-_?V[P$T!X
M[BDW:A0)Z08>;9=FI5QEMQUA+R$*4D@*4VKDL G)2>1Z&.:HS3,0FT]R+5ZB
MY5&8B8G$3B=T]8WQ]>334^C75)MLR[=QR/EV',)0*2$G@B6#:4>E8 (>'$R
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MJ-NV;.UAVN6;-)E@W\2:!,I"]SB$=?.'&-V>G: WADM5<G%S6=C/+-N37[[
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MV^;S <GJZM$*GK?I0?#A+4--RLW$A^KO6O+<)+5&X:_-"=*$@#=Z  [ZMW2
M^QAT@$ @*SK%?%&TVTRK-\7 7O@ZBRQ?>2RC<XX<A*$)'XREJ2D9Y G)(&3
M?(U+>H&KN@FJ[LI=]%N'5B_J(NH/T6E3)?--E);:J7I[)P =@P%$?*<</7D8
M#HM.OBWM:/$1H]-6-/)J3-IR50K-PJ:0?^2R[)B6:EWLCT/*<6L<,^H!LG&(
M#Z:'2 0" \-S5:0H%N3]=JK_  )&F2KLW-.[2KAM-H*UJP.9PD$X'. ^6O#=
MJCIMJ9K!5=2+MO"C?#U;I[U+MJU>/Q7Z52&PMUTN)2"/,/!"G%@9*4A*<GH
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M @,,L,LJ6III""XK<LI2!N/N?<P$D @$!A0!!! (/(@P'X0PRA0*&D)(Z$)
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M0UL ;4C: V=I&>87SP2ES[2[S0C/P>C42X$TS\7@>=7\GYN(7(#L\ @$ @$
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8 (! (! (! (! (! (! (! (! (! ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
